Mipomersen sodium is the new generic name for Isis Pharmaceuticals' anticholesterol drug ISIS 301012.
Isis Pharmaceuticals has a new generic name for ISIS 301012, its anticholesterol drug in development. It's mipomersen sodium. The Carlsbad, Calif., firm said the drug targets apolipoprotein B-100, which is the protein that carries certain forms of cholesterol in the bloodstream. Isis hopes to offer mipomersen to patients who are unable to achieve target cholesterol levels with statins alone or who are intolerant of these drugs.
Click here to see more articles from Drug Topics Daily News.
To go to the Drug Topics homepage, click here.